부산대학교 도서관

S. Ghorashian; G. Lucchini; R. Richardson; K. Nguyen; C. Terris; J. Yeung; J. Chu; L. Williams; K. Ko; C. Walding; K. Watts; S Inglott; S. Adams; E. Gravett; K. Gilmour; A. Lal; S. Kunaseelan; B. Popova; A. Lopes; Y. Ngai; E. Kokalaki; K. Rao; R. Chiesa; J. Silva; K Mullanfiroze; A. Lazareva; D. Bonney; R Wynn; M. Pule; R. Hough; P. Amrolia

HemaSphere, Vol 6, Pp 160-161 (2022)

GlobeNewswire. January 27, 2020

Maciocia, Paul M; Wawrzyniecka, Patrycja A; Philip, Brian; Ricciardelli, Ida; Akarca, Ayse U; Onuoha, Shimobi C; Legut, Mateusz; Cole, David K; Sewell, Andrew K; Gritti, Giuseppe; Somja, Joan; Piris, Miguel A; Peggs, Karl S; Linch, David C; Marafioti, Teresa; Pule, Martin A

Nature Medicine. December 2017, Vol. 23 Issue 12, p1416, 8 p.

Jon Amund Kyte; Anne Fåne; Martin Pule; Gustav Gaudernack

OncoImmunology, Vol 8, Iss 4 (2019)

孙焕; 杨铭; 张晓俊; 吴迪; 陶智; SUN Huan; YANG Ming; ZHANG Xiaojun; WU Di; TAO Zhi

电子器件. 39(5):1087-1092

Klopp A; School of Medicine, Institute of Virology, Technical University of Munich, Munich, Germany.; Institute of Virology, Helmholtz Zentrum München, Munich, Germany.; German Center for Infection Research (DZIF), Munich Partner Site, Munich, Germany.; Schreiber S; School of Medicine, Institute of Virology, Technical University of Munich, Munich, Germany.; Institute of Virology, Helmholtz Zentrum München, Munich, Germany.; Kosinska AD; School of Medicine, Institute of Virology, Technical University of Munich, Munich, Germany.; Institute of Virology, Helmholtz Zentrum München, Munich, Germany.; German Center for Infection Research (DZIF), Munich Partner Site, Munich, Germany.; Pulé M; Department of Haematology, Cancer Institute, University College London, London, United Kingdom.; Protzer U; School of Medicine, Institute of Virology, Technical University of Munich, Munich, Germany.; Institute of Virology, Helmholtz Zentrum München, Munich, Germany.; German Center for Infection Research (DZIF), Munich Partner Site, Munich, Germany.; Wisskirchen K; School of Medicine, Institute of Virology, Technical University of Munich, Munich, Germany.; Institute of Virology, Helmholtz Zentrum München, Munich, Germany.; German Center for Infection Research (DZIF), Munich Partner Site, Munich, Germany.

Publisher: Frontiers Research Foundation] Country of Publication: Switzerland NLM ID: 101560960 Publication Model: eCollection Cited Medium: Internet ISSN: 1664-3224 (Electronic) Linking ISSN: 16643224 NLM ISO Abbreviation: Front Immunol Subsets: MEDLINE

ENP Newswire. January 28, 2020

McKenzie C; Autolus Therapeutics, London W12 7FP, UK.; El-Kholy M; Autolus Therapeutics, London W12 7FP, UK.; Parekh F; Autolus Therapeutics, London W12 7FP, UK.; Robson M; Autolus Therapeutics, London W12 7FP, UK.; Lamb K; Autolus Therapeutics, London W12 7FP, UK.; Allen C; Autolus Therapeutics, London W12 7FP, UK.; Sillibourne J; Autolus Therapeutics, London W12 7FP, UK.; Cordoba S; Autolus Therapeutics, London W12 7FP, UK.; Thomas S; Autolus Therapeutics, London W12 7FP, UK.; Pule M; Autolus Therapeutics, London W12 7FP, UK.; Department of Haematology, UCL Cancer Institute, University College, 72 Huntley Street, London WC1E 6DD, UK.

Publisher: Cell Press Country of Publication: United States NLM ID: 101581621 Publication Model: eCollection Cited Medium: Print ISSN: 2162-2531 (Print) Linking ISSN: 21622531 NLM ISO Abbreviation: Mol Ther Nucleic Acids Subsets: PubMed not MEDLINE

Pearson AD; ACCELERATE, Europe. Electronic address: andy1pearson@btinternet.com.; Rossig C; University Children´s Hospital Muenster, Pediatric Hematology and Oncology, Germany.; Mackall C; Department of Pediatrics and Medicine, Stanford University, Center for Cancer Cell Therapy, Stanford Cancer Institute, Stanford, CA, USA.; Shah NN; Pediatric Oncology Branch, National Cancer Institute, USA.; Baruchel A; Hôpital Universitaire Robert Debré (APHP) and Université de Paris, France.; Reaman G; US Food and Drug Administration, USA.; Ricafort R; Bristol Myers Squibb Company/Celgene, a BMS Company, USA.; Heenen D; KickCancer, Belgium.; Bassan A; Syncopation Life Sciences, USA.; Berntgen M; Scientific Evidence Generation Department, Human Medicines Division, European Medicines Agency (EMA), Amsterdam, Netherlands.; Bird N; Solving Kids' Cancer, UK.; Bleickardt E; Novartis, USA.; Bouchkouj N; US Food and Drug Administration, USA.; Bross P; US Food and Drug Administration, USA.; Brownstein C; Cellectis, USA.; Cohen SB; CRISPR Therapeutics, Switzerland.; de Rojas T; ACCELERATE, Europe.; Ehrlich L; US Food and Drug Administration, USA.; Fox E; St Jude Children's Research Hospital, USA.; Gottschalk S; St Jude Children's Research Hospital, USA.; Hanssens L; Miltenyi Biomedicine, Germany.; Hawkins DS; Seattle Children's Hospital, USA.; Horak ID; Tessa Therapeutics, Singapore.; Taylor DH; Paediatric Oncology Reference Team (PORT), London, UK.; Johnson C; US Food and Drug Administration, USA.; Karres D; Paediatric Medicines Office, Scientific Evidence Generation Department, Human Medicines Division, European Medicines Agency (EMA), Amsterdam, Netherlands.; Ligas F; Paediatric Medicines Office, Scientific Evidence Generation Department, Human Medicines Division, European Medicines Agency (EMA), Amsterdam, Netherlands.; Ludwinski D; Solving Kids' Cancer, USA.; Mamonkin M; Baylor College of Medicine, USA.; Marshall L; The Royal Marsden Hospital and the Institute of Cancer Research, London, UK.; Masouleh BK; Kite, a Gilead Company, USA.; Matloub Y; Takeda Pharmaceuticals International, USA.; Maude S; Children's Hospital of Philadelphia and University of Pennsylvania School of Medicine, Philadelphia, USA.; McDonough J; The Andrew McDonough B+ Foundation, USA.; Minard-Colin V; Department of Pediatric and Adolescent Oncology, INSERM U1015, Gustave Roussy, Université Paris-Saclay, Villejuif, France.; Norga K; Antwerp University Hospital, Paediatric Committee of the European Medicines Agency, Federal Agency for Medicines and Health Products, Belgium.; Nysom K; Rigshospitalet, Denmark.; Pappo A; St Jude Children's Research Hospital, USA.; Pearce L; GlaxoSmithKline, USA.; Pieters R; Princess Maxima Center for Pediatric Oncology, Netherlands.; Pule M; Autolus Limited, UK.; Quintás-Cardama A; TCR(2) Therapeutics, USA.; Richardson N; US Food and Drug Administration, USA.; Schüßler-Lenz M; Chair of CAT (Committee for Advanced Therapies), European Medicines Agency (EMA), Amsterdam, Netherlands; Paul-Ehrlich-Institut, Germany.; Scobie N; Zoe4Life, Switzerland.; Sersch MA; Gracellbiotechnologies Inc, China.; Smith MA; National Cancer Institute, USA.; Sterba J; University Hospital Brno, Masaryk University, Brno, Czech Republic.; Tasian SK; Children's Hospital of Philadelphia and University of Pennsylvania School of Medicine, Philadelphia, USA.; Weigel B; University of Minnesota, USA.; Weiner SL; Children's Cancer Cause, USA.; Zwaan CM; Princess Maxima Center for Pediatric Oncology, Netherlands; Haematological Malignancies Co-Chair Innovative Therapies for Children with Cancer Consortium (ITCC), Europe; Erasmus University Medical Center Rotterdam, Netherlands.; Lesa G; Paediatric Medicines Office, Scientific Evidence Generation Department, Human Medicines Division, European Medicines Agency (EMA), Amsterdam, Netherlands.; Vassal G; ACCELERATE, Europe; Department of Pediatric and Adolescent Oncology, Gustave Roussy, Université Paris-Saclay, Villejuif, France.

Publisher: Elsevier Science Ltd Country of Publication: England NLM ID: 9005373 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1879-0852 (Electronic) Linking ISSN: 09598049 NLM ISO Abbreviation: Eur J Cancer Subsets: MEDLINE

Hotblack A; Department of Haematology, UCL Cancer Institute, University College, 72 Huntley Street, London, WC1E 6DD, UK.; Kokalaki EK; Autolus Therapeutics, White City, London, UK.; Palton MJ; Department of Haematology, UCL Cancer Institute, University College, 72 Huntley Street, London, WC1E 6DD, UK.; Cheung GW; Department of Haematology, UCL Cancer Institute, University College, 72 Huntley Street, London, WC1E 6DD, UK.; Williams IP; Department of Haematology, UCL Cancer Institute, University College, 72 Huntley Street, London, WC1E 6DD, UK.; Manzoor S; Autolus Therapeutics, White City, London, UK.; Grothier TI; Autolus Therapeutics, White City, London, UK.; Piapi A; Department of Haematology, UCL Cancer Institute, University College, 72 Huntley Street, London, WC1E 6DD, UK.; Fiaccadori V; Department of Haematology, UCL Cancer Institute, University College, 72 Huntley Street, London, WC1E 6DD, UK.; Wawrzyniecka P; Department of Haematology, UCL Cancer Institute, University College, 72 Huntley Street, London, WC1E 6DD, UK.; Roddy HA; Department of Haematology, UCL Cancer Institute, University College, 72 Huntley Street, London, WC1E 6DD, UK.; Agliardi G; Department of Haematology, UCL Cancer Institute, University College, 72 Huntley Street, London, WC1E 6DD, UK.; Roddie C; Department of Haematology, UCL Cancer Institute, University College, 72 Huntley Street, London, WC1E 6DD, UK.; Onuoha S; Autolus Therapeutics, White City, London, UK.; Thomas S; Autolus Therapeutics, White City, London, UK.; Cordoba S; Autolus Therapeutics, White City, London, UK.; Pule M; Department of Haematology, UCL Cancer Institute, University College, 72 Huntley Street, London, WC1E 6DD, UK. m.pule@ucl.ac.uk.; Autolus Therapeutics, White City, London, UK. m.pule@ucl.ac.uk.

Publisher: Nature Publishing Group Country of Publication: England NLM ID: 101563288 Publication Model: Electronic Cited Medium: Internet ISSN: 2045-2322 (Electronic) Linking ISSN: 20452322 NLM ISO Abbreviation: Sci Rep Subsets: MEDLINE